Table 3 Prevalence of comorbidities in the study cohort
From: Do acute elevations of serum creatinine in primary care engender an increased mortality risk?
Variable | Total (47,716) | No AKI (n = 43,960) | AKI 1 (n = 3,442) | AKI 2 (n = 223) | AKI 3 (n = 91) | P-value(*) |
|---|---|---|---|---|---|---|
Co - morbidity | ||||||
AIDS (%) | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.71 |
Malignancy** (%) | 6.7 | 6.0 | 14.2 | 19.7 | 18.7 | <0.001 |
CHF (%(%) | 3.0 | 2.2 | 11.8 | 19.3 | 4.4 | <0.001 |
COPD (%) | 9.1 | 8.6 | 15.2 | 15.7 | 11.0 | <0.001 |
Stroke/TIA (%) | 4.3 | 3.9 | 9.0 | 12.6 | 6.6 | <0.001 |
Dementia (%) | 0.8 | 0.7 | 2.1 | 2.7 | 0.0 | <0.001 |
Diabetes (%) | 11.8 | 10.9 | 22.3 | 24.2 | 24.2 | <0.001 |
Hemiplegia (%) | 1.0 | 1.0 | 1.5 | 1.8 | 2.2 | 0.01 |
Hypertension (%) | 28.0 | 26.2 | 48.6 | 56.1 | 55.0 | <0.001 |
MI (%) | 4.1 | 3.7 | 8.5 | 10.3 | 4.4 | <0.001 |
Solid tumour** (%) | 1.1 | 0.9 | 2.5 | 7.2 | 4.4 | <0.001 |
Liver disease (%) | 1.0 | 0.9 | 2.1 | 4.9 | 0.0 | <0.001 |
PVD (%) | 2.3 | 1.9 | 7.0 | 6.3 | 8.8 | <0.001 |
Peptic ulcer (%) | 0.6 | 0.5 | 1.5 | 2.2 | 1.1 | <0.001 |
CKD (%) | 3.1 | 1.9 | 16.9 | 14.8 | 37.4 | <0.001 |
Rheumatic dis. (%) | 3.4 | 3.1 | 6.6 | 9.4 | 7.7 | <0.001 |
Charlson score: | ||||||
≤0 | 64.3 | 66.9 | 34.1 | 28.3 | 22.0 | <0.001 |
1-10 | 23.5 | 22.8 | 31.2 | 24.7 | 38.5 | |
11+ | 12.3 | 10.3 | 34.7 | 47.1 | 39.6 | |